ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05218	Melanoma	3/9	85/7206	0.000126425853736
ko05224	Breast cancer	3/9	174/7206	0.00104428194948
ko05200	Pathways in cancer	4/9	492/7206	0.00205144677086
ko05223	Non-small cell lung cancer	2/9	66/7206	0.00285369649097
ko04923	Regulation of lipolysis in adipocytes	2/9	77/7206	0.00386504399902
ko05214	Glioma	2/9	79/7206	0.00406450852847
ko05212	Pancreatic cancer	2/9	83/7206	0.00447765532781
ko05220	Chronic myeloid leukemia	2/9	85/7206	0.00469129860804
ko04917	Prolactin signaling pathway	2/9	87/7206	0.00490962923218
ko05222	Small cell lung cancer	2/9	89/7206	0.00513262783031
ko05162	Measles	2/9	120/7206	0.0091717452116
ko04151	PI3K-Akt signaling pathway	3/9	390/7206	0.0103464956159
ko05161	Hepatitis B	2/9	173/7206	0.0184645137189
ko00533	Glycosaminoglycan biosynthesis - keratan sulfate	1/9	15/7206	0.0185893888045
ko04218	Cellular senescence	2/9	177/7206	0.0192805568356
ko04150	mTOR signaling pathway	2/9	184/7206	0.0207455716322
ko05167	Kaposi's sarcoma-associated herpesvirus infection	2/9	191/7206	0.0222569716262
ko00515	Mannose type O-glycan biosynthesis	1/9	25/7206	0.0308110342845
ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	1/9	28/7206	0.0344510502838
ko05320	Autoimmune thyroid disease	1/9	29/7206	0.0356616856344
ko00514	Other types of O-glycan biosynthesis	1/9	30/7206	0.0368709715245
ko04392	Hippo signaling pathway -multiple species	1/9	31/7206	0.038078909269
ko00052	Galactose metabolism	1/9	33/7206	0.0404907455841
ko04015	Rap1 signaling pathway	2/9	278/7206	0.0446280978217
ko04014	Ras signaling pathway	2/9	279/7206	0.0449210513802